Clinical Trial Update: The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji Granules [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for Huollingshengji granules in amyotrophic lateral sclerosis is reported, with current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Huollingshengji granules

Snippet

Sponsor: Peking University Third Hospital | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: UNKNOWN